Prof. Yinnong Zhao 赵荫农
Chief Physician, Professor
Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and surgical treatment of tumors in the liver, gallbladder, pancreas, gastrointestinal tract, breast, and body surface. Specializes in comprehensive surgical care for liver cancer, pancreatic cancer, and breast cancer.
Dr. Zhao is a Chief Physician, Professor, and Director of Hepatobiliary and Breast Surgery with a Master of Medicine degree. Trained in Singapore, Dr. Zhao conducts clinical research on high-intensity focused ultrasound and interventional therapies for liver cancer. The doctor has received Second and Third Class Guangxi Science and Technology Progress Awards.
Professional roles
- Standing Committee Member, Guangxi Anti-Cancer Association
- Vice Chair and Secretary, Liver Cancer Professional Committee
- Member, China Pancreatic Cancer Professional Committee
- Editorial Board Member, Guangxi Medical Journal
Name order: in Chinese the family name comes first (Zhao Yinnong). Papers usually list the name as Yinnong Zhao or Zhao Y.
Selected publications
7 papers on PubMed matched by name and affiliation; 5 as first or senior author since 2016. Most recent first- or senior-author papers:
- Cancer Manag Res, 2025 (senior author): Risk Factors of Non-Classic Radiation-Induced Liver Disease (ncRILD) After Intensity-Modulated Radiotherapy in Hepatocellular Carcinoma. PubMed 40546439
- Medicine (Baltimore), 2025 (senior author): Postoperative radiotherapy for stage pIIIA-N2 non-small cell lung cancer patients undergoing sublobar resection: A retrospective cohort study. PubMed 39928784
- J Gastrointest Oncol, 2022 (senior author): Molecular subtyping and IMScore based on immune-related pathways, oncogenic pathways, and DNA damage repair pathways for guiding immunotherapy in hepatocellular carcinoma patients. PubMed 36636061
- World Neurosurg, 2022 (senior author): A Novel Risk Signature with Seven Pyroptosis-Related Genes for Prognosis Prediction in Glioma. PubMed 34929369
- BMC Cancer, 2020 (senior author): Development and validation of an RNA binding protein-associated prognostic model for hepatocellular carcinoma. PubMed 33228611
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion